Tools
Apoptosis Assistant
Close Tool Window
Print Page
Inducing Agent: All Inducing Agents (-)epigallocatechin-3-gallate (EGCG) DNMT1 genotype and doxorubicin Legionella pneumophila Yersinia enterocolitica strains 16K hPRL or endotoxin-C 17beta-estradiol or staurosporine 254-nm UV-C 4T1/luc (mouse breast cancer cells stably expressing firefly luciferase) with or without zoledronic acid A fully human monoclonal antibody (HGS-ETR1; Mapatumumab) and chemotherapeutic agents A fully human monoclonal antibody (HGS-ETRI; Mapatumumab) and chemotherapeutic agents A23187 calcium ionophor; 3-nitropropionic acid (3-NP) in the absence or presence of calpeptin â-amyloid Acanthamoeba culbertsoni Acanthamoeba royreba Actinomycin D and cycloheximide acute high-dose photodynamic therapy (aPDT) or metronomic photodynamic therapy (mPDT) with or without ALA Ad337 or Ad309 followed by Cisplatin or Paclitaxel Ad5-CMVLacZ Adenoviral delivery of dominant negative form of Akt Adenoviral transduction of GSKbeta3 Adenoviral vector expressing human p27 adenoviral vector expressing the dominant-negative forms of IKK-2 or GFP Adenovirus vector expressing MAPK-upstream protein kinase adenoviruses encoding wild-type or dominant-negative Akt adriamycin aged glucagon aging Akt-expressing adenovirus infection and oxygen ALK2 genotype alpha-beta T cell knockout constructs and interferon gamma transgenic alpha-CD152 Fab or hamster control Fab fragments Aminoguanidine (AMG) amyloid-beta [A beta(1–40)] anisomycin anoxia with or without CO anti-Bcl-2-scFv- anti-Bcl-2-scFv-TAT anti-EGFR monoclonal antibody (C225) anti-Fas Ab with or without TGF- beta1; TGF-beta 1 alone Anti-FAS Antibody anti-FAS mAb anti-Fas monoclonal antibody and cycloheximide anti-MDM2 antisense or mismatch control oligonucleotide added to cells with or without androgens in the media anti-mouse CD3; anti-mouse CD28; dexamethasone; UV irradiation anti-mouse Fas monoclonal antibody antisense morpholino oligonucleotide antisense random morpholino oligonucleotides or ISS1A and ISS2B morpholino oligonucleotides Apo2L/TRAIL, Taxol, or combinations Ara-C, etoposide, vincristin with or without butyrate AraC, VP16 or FAS-ligand Arginine vasopressin gene mutant constructs and valproic acid Arginine-glycine-aspartate synthetic peptide argininosuccinate synthase and control siRNA argininosuccinate synthase siRNA with NO donor Glyco-SNAP-2 arsenic trioxide (As2O3) with or without z-VAD-fmk aspirin Aß peptide with or without paclitaxel pretreatment avian coronavirus infectious bronchitis virus (IBV) balloon catheter in the aorta with or without CGRP gene transfer beta-amyloid Betulinic Acid bleomycin instillation with or without AxCAp21, an adenovirus containing a human p21 gene blood filtration BPR0L075 breast cancer cell conditioned medium Bromocriptine bruceantin C225 and paclitaxel C2-ceramide C2-ceramide or C2-dihydroceramide Ca2+ and z-VAD-fmk Ca2+ and Z-VAD-FMK cadmium chloride calcitriol with or without z-VAD-FMK Cam KIV,Cam KK mutants Camptothecin camptothecin (CPT) or homocamptothecin (hCPT) camptothecin--after 30 min pretreatment with cisplatin alone or with calpeptin or cathepsin inhibitor I (CI) or ALLM peptide Capn4 genotype Capsulin knockout constructs carbon tetrachloride cardioplegic arrest (CA) with cardiac bypass (CPB) and hypothermia followed by reperfusion Caspase-2 expression via transfection of caspase-2 expressing clone cell-permeable Ca2+ chelator BAPTA-AM Cerebrospinal fluid from multiple sclerosis patients CGRP peptide chemicals cigarette smoke extract (CSE) cigarette smoke or air cisplatin co-culture with fibroblasts (FB), FB supernatants or FB sonicates either stimulated with IL-1beta or TNF-alpha or unstimulated colchicine C-reactive protein (CRP) with or without pretreatment cSN50 peptide or DMSO cSN50 peptide or SM peptide ctsb-RFP co-transfected with GFP-truncated FADD, CrmA or pretreated with IETD-fmk plus TNF-alpha/actinomycin D(AcD) culturing curcumin, isopentenyl pyrophosphate (IPP) or both cyanoketone (steroid synthesis inhibitor) cyclin D1 gene knockout constructs Cycloheximide cytochalasin B and fMLP daunorubicin DEA-NO dexamethasone diosgenin DNA topoisomerase I inhibitor CPT Docetaxel Dominant negative mutation of MEF2 and retinoic acid treatment Dominant negative mutation of p38 alpha and retinoic acid treatment dopamine doxycycline DR4-A and siRNAs dutasteride E-cadherin antibody or EGTA Edd genotype EGF removal eIF5A siRNA then TNF-alpha with or without camptothecin electric fields (EF) Emp2A deletion genotype endothelin-1 (ET-1), hydrogen peroxide (H2O2), diethyldithiocarbamate (DETC), or ascorbic acid environmental exposure epicatechin gallate (ECG) Epoetin Alfa ET1 8-OCH3 (1-O-octadecyl-2-O-methyl-sn-glycero-3-phosphocholine) ET-18-OCH3 (edelfosine), BM 41.440 (ilmofosine), Concanavalin A Eta knockout constructs ethyl eicosapentaenoate (EPA) followed by irradiation Etoposide with or without ammonium pyrrolidinedithiocarbamate (PDTC) or one of several experimental compounds etoposide with or without cyclosporin A (CsA) EUK-134 Expanded polyglutamine tract human androgen receptor expanded polyQ repeats on ataxin-2 gene expression of G2A Extract of Ganoderma lucidum (Reishi or Ling-Zhi) polysaccharides (EORP) or LPS Fas antibody + PD 98059 Fas antibody with PD 98059 + Z-DEVD-FMK FAS siRNA, HER2 siRNA or both Flathead spontaneous mutation flavopiridol, trastuzumab or both Francisella tularensis LVS strain or staurosporine fucoidan or oxidized low density lipoprotein (OxLDL) Galpha13 wildtype or mutants gamma irradiation genotype genotype and aging genotype and culture conditions genotype and temperature genotype with or without testosterone replacement therapy (TRT) GFP-apoptin expression GGTI-287 goat anti-mouse Ig F(ab')2 gp120IIIb H2O2 and/or Bcl-2 overexpression H2O2, camptothecin (CPT) or teniposide (VM-26) hemin with or without Z-VAD-FMK or cycloheximide (CHX) hEPO deprivation His-tagged TRAIL or His-tagged control homocysteine with or without Z-VAD-FMK homocysteine with or without z-VAD-fmk HSV-1 derivatives: 17-AH (LAT deletion) or 17-AHRI (17syn+ Hpa I fragment R) HSV-1 mutant dLAT2903 (LAT-) HSV-1 wildtype 17syn+ or mutant strains 17-AHRI, 17-AH, 17-FA94, or 17-FA94R HSV-1 wildtype or deleted latency-associated transcript HSV-1 wildtype17syn+ or mutant strains 17-AHRI, or 17-AH human coronavirus infection Huntingtin cDNA Huntingtin cDNA constructs hydrogen peroxide hyperosmotic medium hyperthermic stress hypertonic conditions with or without SC58236 hypertonic stress with GSKbeta3 inhibitors Hypoglycemia hypoxia hypoxia or cyclohexamide (CHX) hypoxia-reoxygenation Ibandronate ICG-001 or DMSO IFN-alpha,p3A(2'p5'A)2,A(2'p5'A)2 IL-1beta IL-2 alone or with curcumin inactivation of Cdc13p incubation at the restrictive temperature indolyldihydroxyquinones derivatives indomethacin, NS398 or SC560 injected 9L gliosarcoma injected control or antisense oligonucleotide to Smad8 injected VX2 papilloma–derived squamous cell carcinoma Inorganic carbon integrin alpha1 genotype and adriamycin (ADR) ionizing radiation irradiation ischemia/reperfusion (I/R) with or without BRL-49653 JO2 anti-Fas antibody lactacystin proteasome inhibitor with or without Z-DEVD-FMK lipopolysaccharide (LPS) lipoprotein from C57BLmice expressing mouse and human ApoE Listeria monocytogenes (LM 10403 serotype 1) secondary infection LOS (H. somnus) strain 127 P low serum LPS and IFN-gamma lung transplants exposed to CO mAChR genotype with wounding Maedi–visna virus (MVV) strain K1514 mercuric, methylmercury or aluminum chloride methylcyclopentadienyl manganese tricarbonyl (MMT) mevastatin, lovastatin or simvastatin (cholesterol synthesis inhibitors) MG132 (z-Leu-Leu-Leu-CHO) microtubule-interacting drugs (baccatin III, analogs 5 and 18) mixture of supernatants from HIV-1-infected and uninfected Molt4/CCR5 cells with or without MAb 5A4 MLP msBLP Msh6 genotype with cisplatin, 6-TG or MNNG exposure Murine S334ter-3 rhodopsin mutant Myelin basic protein Myelin-basic-protein NAC and/or STS NaCl NDGA or baicalein nephrectomy Netrin-1 and Lysophosphatidic acid (LPA) NGF withdrawal NgTRF1 transgene nimesulide NIPP1 genotype NMDA NMDA with or without M-CSF N-methyl-D-aspartate (NMDA) with or without 8-hydroxy-2-(di-n-propylamino)-tetralin (8-OH-DPAT) noradrenaline (NA) or isoproterenol (ISO) normoxia or hypoxia with or without DETA-NO normoxia, intermittent or sustained hypoxia NS-398 NT8R (ssDNA oligo):Cellfectin complexes occlusion with or without estrogen orexin-B overexpressing expanded poly(Q) repeats Oxidized Phospholipid POVPC or PGPC P15 cyclic peptide Paclitaxel paclitaxel and the epothilones individually paclitaxel with or without antioxidants [superoxide dismutase (SOD), catalase, ascorbic acid or glutathione (GSH)] PACT constructs Pam3Cys partially purified leukotoxin from Mannheimia (Pasteurella) haemolytica A1 PD180970, PD164199 or imatinib PDG with or without caspase-8 inhibitor; PDG with or without FADD-DN expression PDG with or without caspase-9 inhibitor; PDG with or without FADD-DN expression PDG with or without FADD-DN expression Pdx1 locus Pf20 genotype phosphotyrosyl phosphatase activator (PTPA) Pigeon-Origin Isolates of Newcastle Disease Virus (PPMV) Porin pregnancy primed by TPA and treated with IFN-alpha Procaspase-9 overexpression PS-1/Mutant PS-1 and retinoic acid PS-1/PS-2 (Presenilin) antisense probes and retinoic acid Pseudomonas aeruginosa--low-Fe PAO1 strain or a high-Fe PAO1 strain purified hamster anti-mouse Fas monoclonal antibody clone Jo2 quercetin Radiation recombinant adeno-associated virus (rAAV) expressing RPE65 cDNA recombinant glycosylated HIV-1 (strain SF2) gp120 recombinant MTF/L47 protein recombinant TRAIL with the addition of recombinant OPG or HT29-conditioned media (CM) with or without anti-OPG Mab RelA genotype Retinoic acid retrovirus overexpressing TBX5 rFasL RGDS, Orbofiban, Xemilofiban, Hypoxia Rimcazole (Rim) in the presence or absence of sigma-1 agonists rituximab (RTX) RNAi or MG132 RON siRNA vector rubella virus or etoposide ryanodine, thapsigargin or palmitate salt stress (NaCl) SB203580 sBLP SC58236 (COX 2 inhibitor) SC58236 with or without dehydration scolopamine plus continuous air flow SDF-1 or mouse anti-human CXCR4 antibody SEA (Staphylococcal enterotoxin A) Semaphorin 3A sepsis Serum deprivation serum deprivation or SNAP serum starvation and genotype serum starvation with or without rhVEGF serum-starvation Sgk3 genotype Shear stress Shigella Flexneri M90T wild-type Shigella Flexneri type 1A LPS short stature homeobox-containing gene (SHOX) silibinin or UV irradiation or both simvastatin SKF104976 Smac expression plasmid and UV irradiation SNAP (S-nitro-N-acetyl-DL-penicillamine) SNAP (S-nitro-N-acetyl-DL-penicillamine) and retinoic acid S-nitroso-N-acetylpenicillamine (SNAP) Sonic hedgehog (Shh) protein with or without CUR61414 Spinal cord injury sponaneous spontaneous Spontaneous apoptosis Staphylococcus aureus (RN6390 wild-type strain) Staurosporine staurosporine or chelerythrine Staurosporine, dexamethasone, anti-Fas antibody, TNF-alpha and actinomycin-D, anti-CD3 antibody STI571 or etoposide SU6656 surgical removal of teste to abdomen tadpole tail regression Tail regression during metamorphosis tamoxifen Temperature sensitive p53 plasmid and temperature shift Temperature shift TNBS TNF-alpha TNF-alpha and actinomycin-D TNF-alpha and cycloheximide TNFalpha or estradiol/TNFalpha TNF-alpha plus cycloheximide TNF-alpha with or without crystals of calcium pyrophosphate dihydrate (CPPD) TNF-alpha, cycloheximide (CHX) or anisomycin (Ani) Topotecan TPA or K14delNLef1 transgene TRAIL TRAIL antibody and siRNAs transfected with GFP-ataxin-2[Q22], GFP-ataxin-2[Q58], or GFP-ataxin-2[Q104] or with HA-ataxin-2 constructs transfection HDMCP transfection of caspase-2 and various deletion mutants Transgenic plakoglobin mouse model trastuzumab, cerulenin or both trastuzumab, pertuzumab, or both Triapine Triapine® triazoloacridines triptolide with or without Z-VAD-FMK troxacitabine and imatinib mesylate (IM) TSA (Trichostatin-A) tubuloside B and/or TNFalpha tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) U18666A U6 hairpin siRNA vector for Akt1, Akt2, Akt1 and Akt2, or XASH3 (control) UO126 Usutu virus UV UV irradiation or etoposide UV irradiation with or without heat shock UVA irradiation, 4-hydroxynonenal (4-HNE) or xanthine (XA) + xanthine oxidase (XO) UV-b irradiation with or without CUR61414 UV-B light UVB or camptothecin UVC UV-C radiation various isothiocyanates (ITC) various monoclonal antibodies (mAb) with or without IL-5 various sigma ligands (PB28, AC927, (+)-pentazocine, DTG or haloperidol various sigma ligands [PB28, AC927, (+)-pentazocine, DTG or haloperidol] VEGF Visna virus strain K1514 (VMV) infection with or without AZT Visna virus strain K1514 infection von-Hippel Lindau tumor suppressor gene transfection and serum withdrawal VP-16 Wild type angiotensin receptor Wild type angiotensin receptor and angiotensin II wild-type or mutant IP3R1 with STS wounding or anti-Fas antibody wounding with or without basic fibroblast growth factor (bFGF) Xanthine and Xanthine Oxidase xenograft of human pancreatic cancer cells to mouse flank X-ray irradiation and/or SU11248 zoledronic acid Cell line or Tissue Type: All Cell and Tissue Types 1547 253J B-V 293 T cells 294 T cells 32Dp210Bcr-Abl 3A 6689 786-0 cells 9L A11 A12 A19 A498 A549 cells A6 A7r5 cells abdominal aortic tissue acute myeloid leukemia blasts APL NB4 ARPE-19 Avian primary erythroblasts B cells BACE BAECs BALB/c 3T3 BCBL-1 betaTC-3 cells BJAB cell line BLEC Bovine pulmonary artery endothelial cells brain tissue BT-474 BY-2 C2 C33 cell line C6 Calu-1 CCD-841Co central nervous system tissue Cerebellar granule neurons Chang liver Chicken spleen sections CHO-K1 Ciona intestinalis Colo205 Colon sections corpus luteum cortical neurons Cos-1 CP70 cryptorchid testes CST1 cultured lenses cytotrophoblasts D407 dendritic cells Dev Dorsal skin sections DT40 DU145 embryonic aorta embryonic brain embryonic cerebrocortical culture embryos embryos, sectioned Eol-1 eosinophil EPCs epidermal sheets epithelial layer of lens capsules ES2 eye eye tissue F3 F9 cells FPASMC Gastric epithelial mucosa GH3 cells glial cells glioblastoma multiforme tumor tissue granulosa H1 H146 H209 H2122 H441 H446 H460 H526 H9 H929 H9c2 hair follicles hatching larvae HCT116 HD-LM2 heart tissue HEK 293 cells HeLa cells HeLa cells stably expressing (API2)-MALT1 HeLa M cells HeLa SS6 hemocytes Hep3B HepG2 hFOB1.19 HGF-2 hind limb tumors hippocampal homogenate Hippocampal Pyramidal Neurons hippocampus HL-60 cells HNSCC biopsies HSC-2 HT-29 HT29-D4 hTERT-BJ1 HTR8 Human melanoma cells HUVEC Ileum of male albino Wistar rats IMR90-E1A caspase-9 DN IMR90-E1A cells IP3R-KO islet-enriched fractions J774 J774A.1 Jurkat cells JURL-MKI K562 KB cells KBM7-R kidney homogenate kidney tissue L2 L929 cells LC (line 506) left ventricle anterior wall lenses liver liver homogenate Liver tissue LNCaP lung parenchyma lung tissue M213-2O macrophages MAC-T mammary tumor cells Marrow preparations mC5 cell line MCF-7 cells McNtcp.24 MCs MDA-231 cells MDA453 MDA-MB-468 MDCK cell line MEF melanoma cells Mesenteric LN and spleen tissue sections Meso13 metanephroi metastatic tumor tissues MG5 middle cerebral artery mIMCD3 MIN6 MKN 28 MOD cells MOLT-4 Mononuclear phagocytes Mouse backskin sections Mouse Ganglia Multiple tissue sections Murine L929 cells Murine macrophages Naive CD4+ T cells nasal polyp eosinophils NB69 cells NCI-H460 Neonatal cardiomyocytes Neuro2a cells Neutrophils NHK NIH 3T3 cells NMUMG NRK NT2 cells P19 cells P388 P388/CPT45 pancreatic islet PASMCs PC12 cells PC-3 Peridinium gatunense periovulatory granulosa peripheral blood monocytes/macrophages Peyer's Patches pistils PMNs PNKT-1 POF posterior oral cavity epithelium Primary cardiomyocytes Primary cerebellar cells Primary cerebral cortex neuronal cells primary cortical neurons primary fetal pulmonary arterial smooth muscle primary fibroblast primary hippocampal neurons primary keratinocytes Primary microglial cell cultures Primary mouse embryonic fibroblasts (MEFs) Primary neuronal cultures primary neurons Primary normal bronchial epithelial Primary normal keratinocytes primary oligodendrocyte progenitor primary pulmonary artery endothelial Primary Rat Striatal Neural Cultures primary T-cells primary VSMCs R179 R182 RA FLS Rabbit trigeminal ganglia neurons Rat oligodendrocyte progenitors and immature oligodendrocytes Rat retinas Rat-1 RBL RD-ES renal medullary interstitial cells Retinal cells Retinas RINm5F RK13 RL95-2 RMIC cell line RPMI 8226 RPT RSC RSF S. cerevisiae Cdc13p ts mutants Saos-2 SCPC seminiferous tubules SH-SY5Y cells SH-SY5Y-SPA4CT SIGC SKBR3 SKH-hr1 mouse skin samples skin skin punches Skin sections skin wounds SK-N-MC SK-N-SH SN56 cell line SNU-398 sperm Spinal cord tissue sections from C57BL/6 mice Spinal cord tissue sections from PLSJLF1/J mice spleen splenocytes Sprague-Dawley E14 rat midbrain neurons ST ST486 stomach stomach tissue SU.86.86 SUDHL-4 sup+ and sup- cell lines Superior cervical ganglion sympathetic neurons SVC1 cell line SW480 SW620 Swiss 3T3 TC-1 term placenta testes testicular sections Th1 Th2 THP-1 Thymocyte Thymocytes T-lymphocytes Transverse tissue sections trigeminal ganglia Trypanosoma brucei brucei TTn tumor tumor cell mass tumor sample tumor sections tumor tissue U251 U266 U373MG U937 UM-UC-3 Vdelta 2+ T cells Vero cells VH-64 VM10 VSMCs WBC WE-68 WEHI-231 Wistar rat brain slices WM793B X. laevis eye primordia and Growth Cones Xenopus tadpole embryo hematopoietic cells yeast yeast cells Apoptosis Reagent: All Anti-ACTIVE® Caspase-3 pAb Anti-Cytochrome c mAb Anti-PARP p85 fragment pAb Apo-ONE® Homogeneous Caspase-3/7 Assays CaspACE™ Assay System, Colorimetric CaspACE™ Assay System, Fluorometric CaspACE™ FITC-VAD-FMK In Situ Marker Caspase Inhibitor Z-VAD-FMK Caspase-Glo™ 3/7 Assay Caspase-Glo™ 8 Assay Caspase-Glo™ 9 Assay DeadEnd™ Colorimetric TUNEL System DeadEnd™ Fluorometric TUNEL System
Inducing Agent: All Inducing Agents (-)epigallocatechin-3-gallate (EGCG) DNMT1 genotype and doxorubicin Legionella pneumophila Yersinia enterocolitica strains 16K hPRL or endotoxin-C 17beta-estradiol or staurosporine 254-nm UV-C 4T1/luc (mouse breast cancer cells stably expressing firefly luciferase) with or without zoledronic acid A fully human monoclonal antibody (HGS-ETR1; Mapatumumab) and chemotherapeutic agents A fully human monoclonal antibody (HGS-ETRI; Mapatumumab) and chemotherapeutic agents A23187 calcium ionophor; 3-nitropropionic acid (3-NP) in the absence or presence of calpeptin â-amyloid Acanthamoeba culbertsoni Acanthamoeba royreba Actinomycin D and cycloheximide acute high-dose photodynamic therapy (aPDT) or metronomic photodynamic therapy (mPDT) with or without ALA Ad337 or Ad309 followed by Cisplatin or Paclitaxel Ad5-CMVLacZ Adenoviral delivery of dominant negative form of Akt Adenoviral transduction of GSKbeta3 Adenoviral vector expressing human p27 adenoviral vector expressing the dominant-negative forms of IKK-2 or GFP Adenovirus vector expressing MAPK-upstream protein kinase adenoviruses encoding wild-type or dominant-negative Akt adriamycin aged glucagon aging Akt-expressing adenovirus infection and oxygen ALK2 genotype alpha-beta T cell knockout constructs and interferon gamma transgenic alpha-CD152 Fab or hamster control Fab fragments Aminoguanidine (AMG) amyloid-beta [A beta(1–40)] anisomycin anoxia with or without CO anti-Bcl-2-scFv- anti-Bcl-2-scFv-TAT anti-EGFR monoclonal antibody (C225) anti-Fas Ab with or without TGF- beta1; TGF-beta 1 alone Anti-FAS Antibody anti-FAS mAb anti-Fas monoclonal antibody and cycloheximide anti-MDM2 antisense or mismatch control oligonucleotide added to cells with or without androgens in the media anti-mouse CD3; anti-mouse CD28; dexamethasone; UV irradiation anti-mouse Fas monoclonal antibody antisense morpholino oligonucleotide antisense random morpholino oligonucleotides or ISS1A and ISS2B morpholino oligonucleotides Apo2L/TRAIL, Taxol, or combinations Ara-C, etoposide, vincristin with or without butyrate AraC, VP16 or FAS-ligand Arginine vasopressin gene mutant constructs and valproic acid Arginine-glycine-aspartate synthetic peptide argininosuccinate synthase and control siRNA argininosuccinate synthase siRNA with NO donor Glyco-SNAP-2 arsenic trioxide (As2O3) with or without z-VAD-fmk aspirin Aß peptide with or without paclitaxel pretreatment avian coronavirus infectious bronchitis virus (IBV) balloon catheter in the aorta with or without CGRP gene transfer beta-amyloid Betulinic Acid bleomycin instillation with or without AxCAp21, an adenovirus containing a human p21 gene blood filtration BPR0L075 breast cancer cell conditioned medium Bromocriptine bruceantin C225 and paclitaxel C2-ceramide C2-ceramide or C2-dihydroceramide Ca2+ and z-VAD-fmk Ca2+ and Z-VAD-FMK cadmium chloride calcitriol with or without z-VAD-FMK Cam KIV,Cam KK mutants Camptothecin camptothecin (CPT) or homocamptothecin (hCPT) camptothecin--after 30 min pretreatment with cisplatin alone or with calpeptin or cathepsin inhibitor I (CI) or ALLM peptide Capn4 genotype Capsulin knockout constructs carbon tetrachloride cardioplegic arrest (CA) with cardiac bypass (CPB) and hypothermia followed by reperfusion Caspase-2 expression via transfection of caspase-2 expressing clone cell-permeable Ca2+ chelator BAPTA-AM Cerebrospinal fluid from multiple sclerosis patients CGRP peptide chemicals cigarette smoke extract (CSE) cigarette smoke or air cisplatin co-culture with fibroblasts (FB), FB supernatants or FB sonicates either stimulated with IL-1beta or TNF-alpha or unstimulated colchicine C-reactive protein (CRP) with or without pretreatment cSN50 peptide or DMSO cSN50 peptide or SM peptide ctsb-RFP co-transfected with GFP-truncated FADD, CrmA or pretreated with IETD-fmk plus TNF-alpha/actinomycin D(AcD) culturing curcumin, isopentenyl pyrophosphate (IPP) or both cyanoketone (steroid synthesis inhibitor) cyclin D1 gene knockout constructs Cycloheximide cytochalasin B and fMLP daunorubicin DEA-NO dexamethasone diosgenin DNA topoisomerase I inhibitor CPT Docetaxel Dominant negative mutation of MEF2 and retinoic acid treatment Dominant negative mutation of p38 alpha and retinoic acid treatment dopamine doxycycline DR4-A and siRNAs dutasteride E-cadherin antibody or EGTA Edd genotype EGF removal eIF5A siRNA then TNF-alpha with or without camptothecin electric fields (EF) Emp2A deletion genotype endothelin-1 (ET-1), hydrogen peroxide (H2O2), diethyldithiocarbamate (DETC), or ascorbic acid environmental exposure epicatechin gallate (ECG) Epoetin Alfa ET1 8-OCH3 (1-O-octadecyl-2-O-methyl-sn-glycero-3-phosphocholine) ET-18-OCH3 (edelfosine), BM 41.440 (ilmofosine), Concanavalin A Eta knockout constructs ethyl eicosapentaenoate (EPA) followed by irradiation Etoposide with or without ammonium pyrrolidinedithiocarbamate (PDTC) or one of several experimental compounds etoposide with or without cyclosporin A (CsA) EUK-134 Expanded polyglutamine tract human androgen receptor expanded polyQ repeats on ataxin-2 gene expression of G2A Extract of Ganoderma lucidum (Reishi or Ling-Zhi) polysaccharides (EORP) or LPS Fas antibody + PD 98059 Fas antibody with PD 98059 + Z-DEVD-FMK FAS siRNA, HER2 siRNA or both Flathead spontaneous mutation flavopiridol, trastuzumab or both Francisella tularensis LVS strain or staurosporine fucoidan or oxidized low density lipoprotein (OxLDL) Galpha13 wildtype or mutants gamma irradiation genotype genotype and aging genotype and culture conditions genotype and temperature genotype with or without testosterone replacement therapy (TRT) GFP-apoptin expression GGTI-287 goat anti-mouse Ig F(ab')2 gp120IIIb H2O2 and/or Bcl-2 overexpression H2O2, camptothecin (CPT) or teniposide (VM-26) hemin with or without Z-VAD-FMK or cycloheximide (CHX) hEPO deprivation His-tagged TRAIL or His-tagged control homocysteine with or without Z-VAD-FMK homocysteine with or without z-VAD-fmk HSV-1 derivatives: 17-AH (LAT deletion) or 17-AHRI (17syn+ Hpa I fragment R) HSV-1 mutant dLAT2903 (LAT-) HSV-1 wildtype 17syn+ or mutant strains 17-AHRI, 17-AH, 17-FA94, or 17-FA94R HSV-1 wildtype or deleted latency-associated transcript HSV-1 wildtype17syn+ or mutant strains 17-AHRI, or 17-AH human coronavirus infection Huntingtin cDNA Huntingtin cDNA constructs hydrogen peroxide hyperosmotic medium hyperthermic stress hypertonic conditions with or without SC58236 hypertonic stress with GSKbeta3 inhibitors Hypoglycemia hypoxia hypoxia or cyclohexamide (CHX) hypoxia-reoxygenation Ibandronate ICG-001 or DMSO IFN-alpha,p3A(2'p5'A)2,A(2'p5'A)2 IL-1beta IL-2 alone or with curcumin inactivation of Cdc13p incubation at the restrictive temperature indolyldihydroxyquinones derivatives indomethacin, NS398 or SC560 injected 9L gliosarcoma injected control or antisense oligonucleotide to Smad8 injected VX2 papilloma–derived squamous cell carcinoma Inorganic carbon integrin alpha1 genotype and adriamycin (ADR) ionizing radiation irradiation ischemia/reperfusion (I/R) with or without BRL-49653 JO2 anti-Fas antibody lactacystin proteasome inhibitor with or without Z-DEVD-FMK lipopolysaccharide (LPS) lipoprotein from C57BLmice expressing mouse and human ApoE Listeria monocytogenes (LM 10403 serotype 1) secondary infection LOS (H. somnus) strain 127 P low serum LPS and IFN-gamma lung transplants exposed to CO mAChR genotype with wounding Maedi–visna virus (MVV) strain K1514 mercuric, methylmercury or aluminum chloride methylcyclopentadienyl manganese tricarbonyl (MMT) mevastatin, lovastatin or simvastatin (cholesterol synthesis inhibitors) MG132 (z-Leu-Leu-Leu-CHO) microtubule-interacting drugs (baccatin III, analogs 5 and 18) mixture of supernatants from HIV-1-infected and uninfected Molt4/CCR5 cells with or without MAb 5A4 MLP msBLP Msh6 genotype with cisplatin, 6-TG or MNNG exposure Murine S334ter-3 rhodopsin mutant Myelin basic protein Myelin-basic-protein NAC and/or STS NaCl NDGA or baicalein nephrectomy Netrin-1 and Lysophosphatidic acid (LPA) NGF withdrawal NgTRF1 transgene nimesulide NIPP1 genotype NMDA NMDA with or without M-CSF N-methyl-D-aspartate (NMDA) with or without 8-hydroxy-2-(di-n-propylamino)-tetralin (8-OH-DPAT) noradrenaline (NA) or isoproterenol (ISO) normoxia or hypoxia with or without DETA-NO normoxia, intermittent or sustained hypoxia NS-398 NT8R (ssDNA oligo):Cellfectin complexes occlusion with or without estrogen orexin-B overexpressing expanded poly(Q) repeats Oxidized Phospholipid POVPC or PGPC P15 cyclic peptide Paclitaxel paclitaxel and the epothilones individually paclitaxel with or without antioxidants [superoxide dismutase (SOD), catalase, ascorbic acid or glutathione (GSH)] PACT constructs Pam3Cys partially purified leukotoxin from Mannheimia (Pasteurella) haemolytica A1 PD180970, PD164199 or imatinib PDG with or without caspase-8 inhibitor; PDG with or without FADD-DN expression PDG with or without caspase-9 inhibitor; PDG with or without FADD-DN expression PDG with or without FADD-DN expression Pdx1 locus Pf20 genotype phosphotyrosyl phosphatase activator (PTPA) Pigeon-Origin Isolates of Newcastle Disease Virus (PPMV) Porin pregnancy primed by TPA and treated with IFN-alpha Procaspase-9 overexpression PS-1/Mutant PS-1 and retinoic acid PS-1/PS-2 (Presenilin) antisense probes and retinoic acid Pseudomonas aeruginosa--low-Fe PAO1 strain or a high-Fe PAO1 strain purified hamster anti-mouse Fas monoclonal antibody clone Jo2 quercetin Radiation recombinant adeno-associated virus (rAAV) expressing RPE65 cDNA recombinant glycosylated HIV-1 (strain SF2) gp120 recombinant MTF/L47 protein recombinant TRAIL with the addition of recombinant OPG or HT29-conditioned media (CM) with or without anti-OPG Mab RelA genotype Retinoic acid retrovirus overexpressing TBX5 rFasL RGDS, Orbofiban, Xemilofiban, Hypoxia Rimcazole (Rim) in the presence or absence of sigma-1 agonists rituximab (RTX) RNAi or MG132 RON siRNA vector rubella virus or etoposide ryanodine, thapsigargin or palmitate salt stress (NaCl) SB203580 sBLP SC58236 (COX 2 inhibitor) SC58236 with or without dehydration scolopamine plus continuous air flow SDF-1 or mouse anti-human CXCR4 antibody SEA (Staphylococcal enterotoxin A) Semaphorin 3A sepsis Serum deprivation serum deprivation or SNAP serum starvation and genotype serum starvation with or without rhVEGF serum-starvation Sgk3 genotype Shear stress Shigella Flexneri M90T wild-type Shigella Flexneri type 1A LPS short stature homeobox-containing gene (SHOX) silibinin or UV irradiation or both simvastatin SKF104976 Smac expression plasmid and UV irradiation SNAP (S-nitro-N-acetyl-DL-penicillamine) SNAP (S-nitro-N-acetyl-DL-penicillamine) and retinoic acid S-nitroso-N-acetylpenicillamine (SNAP) Sonic hedgehog (Shh) protein with or without CUR61414 Spinal cord injury sponaneous spontaneous Spontaneous apoptosis Staphylococcus aureus (RN6390 wild-type strain) Staurosporine staurosporine or chelerythrine Staurosporine, dexamethasone, anti-Fas antibody, TNF-alpha and actinomycin-D, anti-CD3 antibody STI571 or etoposide SU6656 surgical removal of teste to abdomen tadpole tail regression Tail regression during metamorphosis tamoxifen Temperature sensitive p53 plasmid and temperature shift Temperature shift TNBS TNF-alpha TNF-alpha and actinomycin-D TNF-alpha and cycloheximide TNFalpha or estradiol/TNFalpha TNF-alpha plus cycloheximide TNF-alpha with or without crystals of calcium pyrophosphate dihydrate (CPPD) TNF-alpha, cycloheximide (CHX) or anisomycin (Ani) Topotecan TPA or K14delNLef1 transgene TRAIL TRAIL antibody and siRNAs transfected with GFP-ataxin-2[Q22], GFP-ataxin-2[Q58], or GFP-ataxin-2[Q104] or with HA-ataxin-2 constructs transfection HDMCP transfection of caspase-2 and various deletion mutants Transgenic plakoglobin mouse model trastuzumab, cerulenin or both trastuzumab, pertuzumab, or both Triapine Triapine® triazoloacridines triptolide with or without Z-VAD-FMK troxacitabine and imatinib mesylate (IM) TSA (Trichostatin-A) tubuloside B and/or TNFalpha tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) U18666A U6 hairpin siRNA vector for Akt1, Akt2, Akt1 and Akt2, or XASH3 (control) UO126 Usutu virus UV UV irradiation or etoposide UV irradiation with or without heat shock UVA irradiation, 4-hydroxynonenal (4-HNE) or xanthine (XA) + xanthine oxidase (XO) UV-b irradiation with or without CUR61414 UV-B light UVB or camptothecin UVC UV-C radiation various isothiocyanates (ITC) various monoclonal antibodies (mAb) with or without IL-5 various sigma ligands (PB28, AC927, (+)-pentazocine, DTG or haloperidol various sigma ligands [PB28, AC927, (+)-pentazocine, DTG or haloperidol] VEGF Visna virus strain K1514 (VMV) infection with or without AZT Visna virus strain K1514 infection von-Hippel Lindau tumor suppressor gene transfection and serum withdrawal VP-16 Wild type angiotensin receptor Wild type angiotensin receptor and angiotensin II wild-type or mutant IP3R1 with STS wounding or anti-Fas antibody wounding with or without basic fibroblast growth factor (bFGF) Xanthine and Xanthine Oxidase xenograft of human pancreatic cancer cells to mouse flank X-ray irradiation and/or SU11248 zoledronic acid
Cell line or Tissue Type: All Cell and Tissue Types 1547 253J B-V 293 T cells 294 T cells 32Dp210Bcr-Abl 3A 6689 786-0 cells 9L A11 A12 A19 A498 A549 cells A6 A7r5 cells abdominal aortic tissue acute myeloid leukemia blasts APL NB4 ARPE-19 Avian primary erythroblasts B cells BACE BAECs BALB/c 3T3 BCBL-1 betaTC-3 cells BJAB cell line BLEC Bovine pulmonary artery endothelial cells brain tissue BT-474 BY-2 C2 C33 cell line C6 Calu-1 CCD-841Co central nervous system tissue Cerebellar granule neurons Chang liver Chicken spleen sections CHO-K1 Ciona intestinalis Colo205 Colon sections corpus luteum cortical neurons Cos-1 CP70 cryptorchid testes CST1 cultured lenses cytotrophoblasts D407 dendritic cells Dev Dorsal skin sections DT40 DU145 embryonic aorta embryonic brain embryonic cerebrocortical culture embryos embryos, sectioned Eol-1 eosinophil EPCs epidermal sheets epithelial layer of lens capsules ES2 eye eye tissue F3 F9 cells FPASMC Gastric epithelial mucosa GH3 cells glial cells glioblastoma multiforme tumor tissue granulosa H1 H146 H209 H2122 H441 H446 H460 H526 H9 H929 H9c2 hair follicles hatching larvae HCT116 HD-LM2 heart tissue HEK 293 cells HeLa cells HeLa cells stably expressing (API2)-MALT1 HeLa M cells HeLa SS6 hemocytes Hep3B HepG2 hFOB1.19 HGF-2 hind limb tumors hippocampal homogenate Hippocampal Pyramidal Neurons hippocampus HL-60 cells HNSCC biopsies HSC-2 HT-29 HT29-D4 hTERT-BJ1 HTR8 Human melanoma cells HUVEC Ileum of male albino Wistar rats IMR90-E1A caspase-9 DN IMR90-E1A cells IP3R-KO islet-enriched fractions J774 J774A.1 Jurkat cells JURL-MKI K562 KB cells KBM7-R kidney homogenate kidney tissue L2 L929 cells LC (line 506) left ventricle anterior wall lenses liver liver homogenate Liver tissue LNCaP lung parenchyma lung tissue M213-2O macrophages MAC-T mammary tumor cells Marrow preparations mC5 cell line MCF-7 cells McNtcp.24 MCs MDA-231 cells MDA453 MDA-MB-468 MDCK cell line MEF melanoma cells Mesenteric LN and spleen tissue sections Meso13 metanephroi metastatic tumor tissues MG5 middle cerebral artery mIMCD3 MIN6 MKN 28 MOD cells MOLT-4 Mononuclear phagocytes Mouse backskin sections Mouse Ganglia Multiple tissue sections Murine L929 cells Murine macrophages Naive CD4+ T cells nasal polyp eosinophils NB69 cells NCI-H460 Neonatal cardiomyocytes Neuro2a cells Neutrophils NHK NIH 3T3 cells NMUMG NRK NT2 cells P19 cells P388 P388/CPT45 pancreatic islet PASMCs PC12 cells PC-3 Peridinium gatunense periovulatory granulosa peripheral blood monocytes/macrophages Peyer's Patches pistils PMNs PNKT-1 POF posterior oral cavity epithelium Primary cardiomyocytes Primary cerebellar cells Primary cerebral cortex neuronal cells primary cortical neurons primary fetal pulmonary arterial smooth muscle primary fibroblast primary hippocampal neurons primary keratinocytes Primary microglial cell cultures Primary mouse embryonic fibroblasts (MEFs) Primary neuronal cultures primary neurons Primary normal bronchial epithelial Primary normal keratinocytes primary oligodendrocyte progenitor primary pulmonary artery endothelial Primary Rat Striatal Neural Cultures primary T-cells primary VSMCs R179 R182 RA FLS Rabbit trigeminal ganglia neurons Rat oligodendrocyte progenitors and immature oligodendrocytes Rat retinas Rat-1 RBL RD-ES renal medullary interstitial cells Retinal cells Retinas RINm5F RK13 RL95-2 RMIC cell line RPMI 8226 RPT RSC RSF S. cerevisiae Cdc13p ts mutants Saos-2 SCPC seminiferous tubules SH-SY5Y cells SH-SY5Y-SPA4CT SIGC SKBR3 SKH-hr1 mouse skin samples skin skin punches Skin sections skin wounds SK-N-MC SK-N-SH SN56 cell line SNU-398 sperm Spinal cord tissue sections from C57BL/6 mice Spinal cord tissue sections from PLSJLF1/J mice spleen splenocytes Sprague-Dawley E14 rat midbrain neurons ST ST486 stomach stomach tissue SU.86.86 SUDHL-4 sup+ and sup- cell lines Superior cervical ganglion sympathetic neurons SVC1 cell line SW480 SW620 Swiss 3T3 TC-1 term placenta testes testicular sections Th1 Th2 THP-1 Thymocyte Thymocytes T-lymphocytes Transverse tissue sections trigeminal ganglia Trypanosoma brucei brucei TTn tumor tumor cell mass tumor sample tumor sections tumor tissue U251 U266 U373MG U937 UM-UC-3 Vdelta 2+ T cells Vero cells VH-64 VM10 VSMCs WBC WE-68 WEHI-231 Wistar rat brain slices WM793B X. laevis eye primordia and Growth Cones Xenopus tadpole embryo hematopoietic cells yeast yeast cells
Apoptosis Reagent: All Anti-ACTIVE® Caspase-3 pAb Anti-Cytochrome c mAb Anti-PARP p85 fragment pAb Apo-ONE® Homogeneous Caspase-3/7 Assays CaspACE™ Assay System, Colorimetric CaspACE™ Assay System, Fluorometric CaspACE™ FITC-VAD-FMK In Situ Marker Caspase Inhibitor Z-VAD-FMK Caspase-Glo™ 3/7 Assay Caspase-Glo™ 8 Assay Caspase-Glo™ 9 Assay DeadEnd™ Colorimetric TUNEL System DeadEnd™ Fluorometric TUNEL System